ATRA Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03

Fiyat $9.48

Piyasa Değeri (MRQ) $90M

P/E (TTM) -5.5

Hisse Başına Kâr (TTM) $-1.73

Gelir (TTM) $6M

ROE (TTM) 46.3%

52 Haftlık Aralık $4–$19

ATRA Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04

aralık

çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

Hisse bölünmeleri 1

Ex-tarihi	Bölünme	Tür
20 Haziran 2024	1-for-25	Ters

Atara Biotherapeutics, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı

05 · wikidata

Wikidata ↗

sektörHealthcare endüstriBiotechnology çalışanlar10 ülkeUS

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06

Gelir$121M

2022-12-31 → 2025-12-31

Hisse Başına Kâr$2.57

2020-12-31 → 2025-12-31

Serbest Nakit Akışı$-51M

2016-12-31 → 2025-12-31

Net kar marjı-269.4%

2023-12-31 → 2025-12-31

Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik	ATRA	5Y ort.	Akran Ortalaması	Sonuç
P/E (TTM)	-5.55Y ort. ≈-27.9	≈-27.9	·	·
F/S (TTM)	14.55Y ort. ≈71.2	≈71.2	70.6	Düşük değerli
F/D (MRQ)	-2.45Y ort. ≈34.7	≈34.7	·	·
Price / FCF (Fiyat / Serbest Nakit Akışı)	-1.45Y ort. ≈-39.1	≈-39.1	·	·
Price / Cash Flow (Fiyat / Nakit Akışı)	-1.45Y ort. ≈-40.7	≈-40.7	·	·
Price / Tangible Book (Fiyat / Maddi Defter Değeri)	7.25Y ort. ≈68.3	≈68.3	·	·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik	ATRA	5Y ort.	Akran Ortalaması	Sonuç
Faaliyet Kâr Marjı (TTM)	-229.7%5Y ort. ≈-1084.8%	≈-1084.8%	-2434.3%	En üst düzey
EBITDA Margin (FAVÖK Marjı)	29.7%5Y ort. ≈-1084.8%	≈-1084.8%	-2434.3%	En üst düzey
Vergi Öncesi Kar Marjı (TTM)	-269.0%5Y ort. ≈-1086.6%	≈-1086.6%	-3416.0%	En üst düzey
Net Kâr Marjı (TTM)	-269.4%5Y ort. ≈-1086.7%	≈-1086.7%	-2336.0%	En üst düzey
ROA (TTM)	-57.6%5Y ort. ≈-46.4%	≈-46.4%	-30.1%	En üst düzey
ROE (TTM)	46.3%5Y ort. ≈21.8%	≈21.8%	-50.0%	Zayıf
ROIC	-93.0%5Y ort. ≈-14.5%	≈-14.5%	-52.7%	Zayıf

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik	ATRA	5Y ort.	Akran Ortalaması	Sonuç
Cari Oran (MRQ)	2.05Y ort. ≈1.9	≈1.9	5.3	Düşük likidite
Cari Oran (MRQ)	1.55Y ort. ≈1.7	≈1.7	3.8	Düşük likidite
Interest Coverage (Faiz Karşılama Oranı)	9.55Y ort. ≈-20.3	≈-20.3	·	·

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik	5 Yıllık trend	ATRA	5Y ort.	Akran Ortalaması	Sonuç
Revenue YoY (Gelir Yıllık Bazda)		-6.3%5Y ort. ≈437.1%	≈437.1%	·	·
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)		23.8%	·	·	·

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik	ATRA	5Y ort.	Akran Ortalaması	Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))	$2.575Y ort. ≈$-15.98	≈$-15.98	·	·
Revenue / Share (Hisse Başına Gelir)	$9.505Y ort. ≈$8.93	≈$8.93	·	·
Cash Flow / Share (Hisse Başına Nakit Akışı)	$-4.015Y ort. ≈$-4.41	≈$-4.41	·	·
Cash / Share (Hisse Başına Nakit)	$1.165Y ort. ≈$1.56	≈$1.56	·	·

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik	ATRA	5Y ort.	Akran Ortalaması	Sonuç
Asset Turnover (Aktif Devir Hızı)	1.95Y ort. ≈0.9	≈0.9	0.0	En üst düzey
Receivables Turnover (Alacak Devir Hızı)	88.35Y ort. ≈31.9	≈31.9	·	·
Revenue / Employee (Çalışan Başına Gelir)	≈$12.1M	·	·	·

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14

Ort. Sürpriz 76.0%

Sonraki Rapor Kas 10, 2026

Dönem	Rapor	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	Ağu 10, 2026	$-0.32	$-0.32	0.40%
31 Mart 2026	May 13, 2026	$-0.29	$-0.41	29.8%
31 Aralık 2025		$-0.25	$-0.17	-43.0%
30 Eylül 2025		$-0.32	$-0.88	63.5%
30 Haziran 2025		$0.19	$-0.47	140.5%
31 Mart 2025		$3.50	$-2.02	273.3%
31 Aralık 2024		$-1.19	$-3.65	67.4%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15

Gelir Tablosu 16

Metrik	2025	2024	2023	2022
Revenue	$121M	$129M	$9M	$64M
R&D Expense	$37M	$151M	$225M	$273M
SG&A Expense	$26M	$40M	$51M	$72M
Operating Expenses	$85M	$212M	$285M	$344M
Operating Income	$36M	$-83M	$-276M	$-281M
Interest Expense	$4M	$5M	$5M	$373.0K
Interest Income	$683.0K	$2M	$5M	$3M
Other Non-op	$-34.0K	$528.0K	$-246.0K	$-700.0K
Pretax Income	$33M	$-85M	$-276M	$-228M
Income Tax	$31.0K	$-12.0K	$15.0K	$12.0K
Net Income	$33M	$-85M	$-276M	$-228M
EPS (Basic)	$2.61	$-11.41	$-65.19	$-2.24
EPS (Diluted)	$2.57	$-11.41	$-65.19	$-2.24
Shares (Basic)	12,544,000	7,488,000	4,236,000	101,990,000
Shares (Diluted)	12,718,000	7,488,000	4,236,000	101,990,000
EBITDA	$36M	$-83M	$-276M	$-281M

Bilanço 23

Metrik	2025	2024	2023	2022
Cash & Equivalents	$8M	$25M	$26M	$93M
Short-term Investments	$0	$17M	$26M	$150M
Receivables	$1M	$1M	$34M	$40M
Inventory	$0	$11M	$10M	$2M
Other Current Assets	$2M	$10M	$6M	$10M
Current Assets	$12M	$65M	$102M	$295M
PP&E (Net)	$73.0K	$1M	$4M	$6M
PP&E (Gross)	$286.0K	$19M	$20M	$19M
Accum. Depreciation	$213.0K	$17M	$16M	$12M
Other Non-current Assets	$886.0K	$3M	$5M	$7M
Total Assets	$20M	$109M	$166M	$376M
Accounts Payable	$127.0K	$4M	$4M	$7M
Accrued Liabilities	$2M	$6M	$19M	$7M
Current Liabilities	$15M	$135M	$142M	$79M
Capital Leases	$9M	$30M	$46M	$58M
Other Non-current Liabilities	$2M	$3M	$5M	$6M
Total Liabilities	$59M	$206M	$265M	$250M
Common Stock	$1.0K	$1.0K	$0	$10.0K
Retained Earnings	$-2.02B	$-2.05B	$-1.97B	$-1.69B
AOCI	$1.0K	$8.0K	$-204.0K	$-2M
Stockholders' Equity	$-39M	$-97M	$99M	$127M
Liabilities + Equity	$20M	$109M	$166M	$376M
Shares Outstanding	7,324,000	5,859,000	4,258,000	95,927,000

Nakit Akışı 13

Metrik	2025	2024	2023	2022
D&A	$2M	$5M	$5M	$6M
Stock-based Comp	$10M	$27M	$45M	$54M
Deferred Tax	$0	$0	·	·
Restructuring	$13M	$5M	$7M	$6M
Operating Cash Flow	$-51M	$-69M	$-193M	$-270M
CapEx	$0	$246.0K	$1M	$4M
Investing Cash Flow	$18M	$9M	$124M	$203M
Stock Issued	$1M	$9M	$2M	$22M
Net Stock Activity	$1M	$9M	$2M	$22M
Financing Cash Flow	$16M	$59M	$2M	$53M
Taxes Paid	$190.0K	$24.0K	$2.0K	$19.0K
Free Cash Flow	$-51M	$-69M	$-194M	$-275M
Levered FCF	$-55M	$-74M	$-199M	·

Kârlılık 7

Metrik	2025	2024	2023	2022
Operating Margin	29.7%	-64.7%	-3219.5%	·
Net Margin	27.1%	-66.2%	-3220.9%	·
Pretax Margin	27.1%	-66.2%	-3220.7%	·
EBITDA Margin	29.7%	-64.7%	-3219.5%	·
ROA	50.5%	-62.2%	-101.9%	-54.1%
ROE	-88.9%	90.9%	368.0%	-145.5%
ROIC	-93.0%	85.8%	278.2%	-221.5%

Likidite ve Solventlik 3

Metrik	2025	2024	2023	2022
Current Ratio	0.8	0.5	0.7	3.7
Quick Ratio	0.7	0.3	0.6	3.6
Interest Coverage	9.5	-18.1	-52.2	·

Verimlilik 2

Metrik	Eğilim	2025	2024	2023	2022
Asset Turnover		1.9	0.9	0.0	·
Receivables Turnover		88.3	7.2	0.2	·

Hisse Başına 5

Metrik	2025	2024	2023	2022
Book Value / Share	$-5.26	$-16.60	$-0.93	$1.32
Revenue / Share	$9.50	$17.22	$0.08	·
Cash Flow / Share	$-4.01	$-9.18	$-1.82	$-2.65
Cash / Share	$1.16	$4.27	$0.24	$0.97
EPS (TTM)	$2.57	$-11.41	$-65.19	$-2.24

Büyüme Oranları 2

Metrik	Eğilim	2025	2024	2023	2022
Revenue YoY		-6.3%	1404.0%	-86.5%	·
Revenue CAGR 3Y		23.8%	·	·	·

Değerleme (TTM) 10

Metrik	2025	2024	2023	2022
Revenue TTM	$121M	$129M	$9M	$64M
Net Income TTM	$33M	$-85M	$-276M	$-228M
Market Cap	$132M	$78M	$1.37B	$7.87B
P/E	7.0	-1.2	-0.2	-36.6
P/S	1.1	0.6	159.2	123.7
P/B	-3.4	-0.8	-13.8	62.1
P / Tangible Book	·	·	13.8	62.1
P / Cash Flow	-2.6	-1.1	-7.1	-29.1
P / FCF	-2.6	-1.1	-7.0	-28.6
Earnings Yield	14.2%	-85.7%	-508.3%	-2.7%

Gelir Tablosu 16

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$630.0K	$516.0K	$2M	$3M	$18M	$98M	$33M	$40M	$29M	$27M	$4M	$2M	$957.0K	$1M	$221.0K	$4M
R&D Expense	$1M	$164.0K	$-223.0K	$3M	$7M	$27M	$29M	$44M	$33M	$46M	$50M	$57M	$56M	$62M	$63M	$70M
SG&A Expense	$4M	$4M	$4M	$4M	$7M	$11M	$9M	$10M	$9M	$11M	$11M	$12M	$13M	$14M	$13M	$19M
Operating Expenses	$5M	$4M	$4M	$7M	$14M	$59M	$45M	$62M	$47M	$59M	$64M	$72M	$72M	$76M	$76M	$89M
Operating Income	$-5M	$-3M	$-3M	$-4M	$3M	$39M	$-12M	$-22M	$-18M	$-31M	$-60M	$-70M	$-71M	$-75M	$-76M	$-85M
Interest Expense	$191.0K	$830.0K	$894.0K	$909.0K	$972.0K	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$117.0K	$123.0K
Interest Income	$78.0K	$54.0K	$100.0K	$204.0K	$143.0K	$236.0K	$597.0K	$459.0K	$450.0K	$604.0K	$711.0K	$1M	$2M	$2M	$1M	$973.0K
Other Non-op	$0	$0	$-49.0K	$4.0K	$22.0K	$-11.0K	$-89.0K	$555.0K	$-6.0K	$68.0K	$-12.0K	$-27.0K	$-10.0K	$-197.0K	$-68.0K	$-309.0K
Pretax Income	$-5M	$-4M	$-3M	$-4M	$2M	$38M	$-13M	$-22M	$-19M	$-32M	$-60M	$-70M	$-71M	$-75M	$-75M	$-84M
Income Tax	$1.0K	$0	$0	$28.0K	$3.0K	$0	$-19.0K	$-17.0K	$0	$24.0K	$11.0K	$-19.0K	$1.0K	$22.0K	$2.0K	$10.0K
Net Income	$-5M	$-4M	$-3M	$-4M	$2M	$38M	$-13M	$-22M	$-19M	$-32M	$-60M	$-70M	$-71M	$-75M	$-75M	$-84M
EPS (Basic)	$-0.32	$-0.29	$-0.80	$-0.32	$0.20	$3.53	$0.27	$-2.93	$-3.10	$-5.65	$-31.16	$-16.40	$-16.91	$-0.72	$-0.73	$-0.82
EPS (Diluted)	$-0.32	$-0.29	$-0.80	$-0.32	$0.19	$3.50	$0.27	$-2.93	$-3.10	$-5.65	$-31.16	$-16.40	$-16.91	$-0.72	$-0.73	$-0.82
Shares (Basic)	15,033,000	14,081,000	·	13,564,000	12,197,000	10,764,000	·	7,466,000	6,143,000	5,623,000	·	4,256,000	4,204,000	103,969,000	·	102,423,000
Shares (Diluted)	15,033,000	14,081,000	·	13,564,000	12,310,000	10,851,000	·	7,466,000	6,143,000	5,623,000	·	4,256,000	4,204,000	103,969,000	·	102,423,000
EBITDA	·	$-3M	·	$-4M	$3M	$39M	·	$-22M	$-18M	$-31M	·	$-70M	$-71M	$-75M	·	$-85M

Bilanço 24

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$3M	$8M	$8M	$6M	$17M	$14M	$25M	$46M	$31M	$35M	$26M	$65M	$46M	$49M	$93M	$65M
Short-term Investments	$7M	·	$0	$8M	$5M	$0	$17M	$21M	$4M	$11M	$26M	$38M	$108M	$157M	$150M	$200M
Receivables	$318.0K	$0	$1M	$2M	$0	$9M	$1M	$1M	$2M	$36M	$34M	$163.0K	$507.0K	$397.0K	$40M	$249.0K
Inventory	·	·	$0	$0	$0	$0	$11M	$14M	$19M	$16M	$10M	$7M	$8M	$5M	$2M	·
Prepaid Expense	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$16M
Other Current Assets	$3M	$4M	$2M	$3M	$2M	$4M	$10M	$9M	$6M	$8M	$6M	$9M	$10M	$13M	$10M	·
Current Assets	$14M	$12M	$12M	$18M	$25M	$27M	$65M	$92M	$62M	$106M	$102M	$119M	$172M	$224M	$295M	$283M
PP&E (Net)	$41.0K	$55.0K	$73.0K	$147.0K	$176.0K	$285.0K	$1M	$2M	$2M	$3M	$4M	$5M	$5M	$6M	$6M	$7M
PP&E (Gross)	·	·	$286.0K	$551.0K	$551.0K	$2M	$19M	$20M	$20M	$20M	$20M	$20M	$20M	$19M	$19M	$20M
Accum. Depreciation	·	·	$213.0K	$404.0K	$375.0K	$2M	$17M	$18M	$17M	$17M	$16M	$15M	$14M	$13M	$12M	$12M
Other Non-current Assets	$765.0K	$890.0K	$886.0K	$881.0K	$927.0K	$3M	$3M	$3M	$4M	$4M	$5M	$6M	$7M	$7M	$7M	$7M
Total Assets	$21M	$20M	$20M	$30M	$37M	$62M	$109M	$143M	$117M	$165M	$166M	$189M	$246M	$302M	$376M	$368M
Accounts Payable	$824.0K	$637.0K	$127.0K	$318.0K	$2M	$1M	$4M	$2M	$5M	$3M	$4M	$7M	$4M	$5M	$7M	$11M
Accrued Liabilities	$2M	$2M	$2M	$3M	$5M	$9M	$6M	$8M	$11M	$18M	$19M	$8M	$11M	$7M	$7M	·
Current Liabilities	$7M	$6M	$15M	$18M	$15M	$48M	$135M	$156M	$148M	$181M	$142M	$79M	$75M	$68M	$79M	$72M
Capital Leases	$9M	$9M	$9M	$15M	$15M	$27M	$30M	$35M	$39M	$42M	$46M	$49M	$52M	$55M	$58M	$61M
Other Non-current Liabilities	$2M	$2M	$2M	$2M	$2M	$3M	$3M	$4M	$4M	$4M	$5M	$5M	$5M	$5M	$6M	$6M
Total Liabilities	$58M	$57M	$59M	$67M	$72M	$117M	$206M	$233M	$228M	$264M	$265M	$240M	$239M	$237M	$250M	$181M
Common Stock	$1.0K	$1.0K	$1.0K	$1.0K	$1.0K	$1.0K	$1.0K	$1.0K	$0	$12.0K	$0	$10.0K	$10.0K	$10.0K	$10.0K	$9.0K
Retained Earnings	$-2.03B	$-2.03B	$-2.02B	$-2.02B	$-2.01B	$-2.02B	$-2.05B	$-2.04B	$-2.02B	$-2.00B	$-1.97B	$-1.91B	$-1.84B	$-1.77B	$-1.69B	$-1.62B
AOCI	$-2.0K	$0	$1.0K	$2.0K	$0	$0	$8.0K	$22.0K	$-14.0K	$-55.0K	$-204.0K	$-571.0K	$-933.0K	$-1M	$-2M	$-3M
Stockholders' Equity	$-37M	$-37M	$-39M	$-37M	$-35M	$-55M	$-97M	$-91M	$-111M	$-98M	$-99M	$-51M	$7M	$65M	$127M	$187M
Liabilities + Equity	$21M	$20M	$20M	$30M	$37M	$62M	$109M	$143M	$117M	$165M	$166M	$189M	$246M	$302M	$376M	$368M
Shares Outstanding	9,443,000	8,512,000	7,324,000	7,210,000	6,978,000	5,924,000	5,859,000	5,740,000	4,904,000	120,325,000	4,258,000	101,922,000	101,102,000	96,538,000	95,927,000	94,879,000

Nakit Akışı 12

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$14.0K	$29.0K	$49.0K	$36.0K	$236.0K	$2M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M
Stock-based Comp	$394.0K	$749.0K	$2M	$1M	$3M	$4M	$6M	$6M	$6M	$8M	$10M	$11M	$13M	$12M	$11M	$14M
Restructuring	$767.0K	$0	$1M	$27.0K	$2M	$10M	$0	$0	$356.0K	$5M	$7M	$0	$0	$45.0K	$74.0K	$6M
Operating Cash Flow	$-3M	$-3M	$-6M	$-10M	$-7M	$-28M	$-24M	$-4M	$-11M	$-30M	$-50M	$-51M	$-53M	$-38M	$-57M	$-65M
CapEx	·	·	$0	$0	$0	$0	$90.0K	$0	$29.0K	$127.0K	$44.0K	$281.0K	$499.0K	$399.0K	$37.0K	$132.0K
Investing Cash Flow	$-7M	$0	$8M	$-2M	$-5M	$17M	$3M	$-17M	$7M	$15M	$10M	$70M	$49M	$-6M	$51M	$60M
Stock Issued	$5M	$3M	$-25.0K	$1M	$0	$0	$0	$0	$-26.0K	$9M	$2M	$0	$-50.0K	$640.0K	$1M	$0
Net Stock Activity	·	$3M	·	·	·	$0	·	·	·	$9M	·	·	·	$640.0K	·	·
Financing Cash Flow	$5M	$3M	$-3.0K	$1M	$15M	$-250.0K	$-328.0K	$36M	$-324.0K	$24M	$2M	$-208.0K	$471.0K	$235.0K	$32M	$-214.0K
Taxes Paid	·	·	$159.0K	$28.0K	$3.0K	$0	$0	$0	$0	$24.0K	$0	$0	$1.0K	$1.0K	$0	$0
Free Cash Flow	·	·	·	·	·	$-28M	·	·	·	$-30M	·	·	·	$-39M	·	·
Levered FCF	·	·	·	·	·	$-29M	·	·	·	$-31M	·	·	·	$-40M	·	·

Kârlılık 7

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	·	-652.9%	·	-103.5%	18.2%	39.5%	·	-54.1%	-63.7%	-114.2%	·	-3255.9%	-7462.3%	-6118.9%	·	·
Net Margin	·	-803.3%	·	-124.6%	13.6%	38.7%	·	-54.5%	-66.5%	-116.1%	·	-3264.6%	-7430.3%	-6098.8%	·	·
Pretax Margin	·	-803.3%	·	-123.8%	13.6%	38.7%	·	-54.6%	-66.5%	-116.0%	·	-3265.5%	-7430.2%	-6097.0%	·	·
EBITDA Margin	·	-652.9%	·	-103.5%	18.2%	39.5%	·	-54.1%	-63.7%	-114.2%	·	-3255.9%	-7462.3%	-6118.9%	·	·
ROA	·	-10.1%	·	-5.0%	3.1%	33.4%	·	-13.2%	-10.5%	-13.6%	·	-25.1%	-20.8%	-21.4%	·	-20.5%
ROE	·	9.0%	·	6.8%	-3.3%	-49.6%	·	31.0%	36.8%	190.4%	·	-102.4%	-53.7%	-51.7%	·	-33.8%
ROIC	·	9.0%	·	9.8%	-9.1%	-70.5%	·	24.0%	16.4%	31.8%	·	136.9%	-958.1%	-115.5%	·	-45.2%

Likidite ve Solventlik 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	·	2.2	·	1.0	1.7	0.6	·	0.6	0.4	0.6	·	1.5	2.3	3.3	·	3.9
Quick Ratio	·	1.5	·	0.9	1.5	0.5	·	0.4	0.3	0.5	·	1.3	2.1	3.0	·	3.7
Interest Coverage	·	-4.1	·	-3.9	3.3	38.2	·	-18.4	-14.4	-27.1	·	-49.9	-51.8	-56.2	·	·

Verimlilik 2

Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		·	0.0	·	0.0	0.2	0.9	·	0.2	0.2	0.1	·	0.0	0.0	0.0	·	·
Receivables Turnover		·	0.1	·	2.1	14.5	4.4	·	53.7	19.6	1.5	·	10.4	1.7	2.3	·	·

Hisse Başına 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	·	$-4.38	·	$-5.08	$-5.02	$-9.30	·	$-15.77	$-22.61	$-0.82	·	$-0.50	$0.07	$0.67	·	$1.97
Revenue / Share	·	$0.04	·	$0.25	$1.43	$9.05	·	$5.38	$4.66	$0.19	·	$0.02	$0.01	$0.01	·	·
Cash Flow / Share	·	$-0.22	·	·	·	$-2.59	·	·	·	$-0.21	·	·	·	$-0.37	·	·
Cash / Share	·	$0.98	·	$0.80	$2.42	$2.34	·	$8.09	$6.39	$0.29	·	$0.64	$0.45	$0.50	·	$0.69
EPS (TTM)	$-0.74	$-1.22	·	$3.64	$1.03	$-2.26	·	$-42.84	$-56.31	$-70.12	·	$-34.76	$-19.18	$-2.09	·	$-2.47

Değerleme (TTM) 9

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$22M	$23M	·	$152M	$189M	$200M	·	$100M	$62M	$35M	·	$5M	$7M	$57M	·	·
Net Income TTM	$-11M	$-9M	·	$23M	$6M	$-16M	·	$-133M	$-181M	$-233M	·	$-290M	$-305M	$-215M	·	$-247M
Market Cap	·	$40M	·	$103M	$54M	$35M	·	$47M	$42M	$2.09B	·	$3.77B	$4.07B	$7.00B	·	$8.97B
P/E	-15.5	-3.9	·	3.9	7.5	-2.6	·	-0.2	-0.2	-0.2	·	-1.1	-2.1	-34.7	·	-38.3
P/S	·	1.7	·	0.7	0.3	0.2	·	0.5	0.7	60.2	·	830.3	592.9	121.8	·	·
P/B	·	-1.1	·	-2.8	-1.5	-0.6	·	-0.5	-0.4	-21.2	·	-74.2	545.9	107.7	·	47.9
P / Tangible Book	·	·	·	·	·	·	·	·	·	·	·	·	545.9	107.7	·	47.9
P / Cash Flow	·	-13.1	·	·	·	-1.3	·	·	·	-70.5	·	·	·	-182.1	·	·
Earnings Yield	-6.5%	-25.8%	·	25.4%	13.3%	-38.0%	·	-526.9%	-662.5%	-404.2%	·	-94.0%	-47.6%	-2.9%	·	-2.6%

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$121M	$129M	$9M	$64M	·
Faaliyet Kâr Marjı %	29.7%	-64.7%	-3219.5%	·	·
Net Gelir	$33M	$-85M	$-276M	$-228M	$-340M
Seyreltilmiş Hisse Başı Kâr	$2.57	$-11.41	$-65.19	$-2.24	$-3.63

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Cari Oran	0.8	0.5	0.7	3.7	3.6
Cari Oran	0.7	0.3	0.6	3.6	3.5

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$-51M	$-69M	$-194M	$-275M	$-231M

Kurumsal Sahipler (13F) 38 dosya · $54.9M toplam · Tarih itibarıyla 30 Haziran 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 38

Tutulan Değer $54.9M

Yeni pozisyonlar 4

Çıkan pozisyonlar 1

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
4 (-3 önceki Ç'ye göre)	1 (-13 önceki Ç'ye göre)	12 (+2 önceki Ç'ye göre)	8 (+5 önceki Ç'ye göre)	+1.9M

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
EcoR1 Capital, LLC	$17.816.960	1.552.000	32,43%	Hisse senetleri
ADAGE CAPITAL PARTNERS GP, L.L.C.	$9.758.000	850.000	17,76%	Hisse senetleri
Point72 Asset Management, L.P.	$7.895.003	687.718	14,37%	Hisse senetleri
Redmile Group, LLC	$5.070.727	441.701	9,23%	Hisse senetleri
VANGUARD GROUP INC	$4.087.255	225.940	7,44%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$2.836.100	247.047	5,16%	Hisse senetleri
MACKENZIE FINANCIAL CORP	$2.677.699	233.249	4,87%	Hisse senetleri
BlackRock, Inc.	$969.544	84.455	1,76%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$862.924	75.128	1,57%	Hisse senetleri
STALEY CAPITAL ADVISERS INC	$574.000	50.000	1,04%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$494.053	43.036	0,90%	Hisse senetleri
JANE STREET GROUP, LLC	$348.360	30.345	0,63%	Hisse senetleri
STATE STREET CORP	$303.680	26.453	0,55%	Hisse senetleri
NORTHERN TRUST CORP	$190.465	16.591	0,35%	Hisse senetleri
FMR LLC	$186.412	16.238	0,34%	Hisse senetleri
XTX Topco Ltd	$175.678	15.303	0,32%	Hisse senetleri
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$160.720	14.000	0,29%	Hisse senetleri
MILLENNIUM MANAGEMENT LLC	$145.566	12.680	0,26%	Hisse senetleri
CITADEL ADVISORS LLC	$116.625	10.159	0,21%	Hisse senetleri
MORGAN STANLEY	$105.368	9.178	0,19%	Hisse senetleri
ROYAL BANK OF CANADA	$55.000	4.743	0,10%	Hisse senetleri
UBS Group AG	$45.679	3.979	0,08%	Hisse senetleri
Vanguard Global Advisers, LLC	$16.715	1.456	0,03%	Hisse senetleri
SBI Securities Co., Ltd.	$16.118	1.404	0,03%	Hisse senetleri
JONES FINANCIAL COMPANIES LLLP	$8.440	803	0,02%	Hisse senetleri
Caitong International Asset Management Co., Ltd	$3.570	311	0,01%	Hisse senetleri
BARCLAYS PLC	$3.490	304	0,01%	Hisse senetleri
Banque Transatlantique SA	$3.096	176	0,01%	Hisse senetleri
WELLS FARGO & COMPANY/MN	$2.881	251	0,01%	Hisse senetleri
JPMORGAN CHASE & CO	$2.413	216	0,00%	Hisse senetleri
Raiffeisen Bank International AG	$2.296	200	0,00%	Alım opsiyonu
CITIGROUP INC	$1.114	97	0,00%	Hisse senetleri
BNP PARIBAS FINANCIAL MARKETS	$528	46	0,00%	Hisse senetleri
ACADIAN ASSET MANAGEMENT LLC	$444	38.845	0,00%	Hisse senetleri
PlanVest Financial, Inc	$321	28	0,00%	Hisse senetleri
KERR FINANCIAL PLANNING Corp	$276	24	0,00%	Hisse senetleri
OSAIC HOLDINGS, INC.	$114	10	0,00%	Hisse senetleri
Rockefeller Capital Management L.P.	$92	8	0,00%	Hisse senetleri

Aktivistler ve %5+ sahipler 3 pozisyon

18

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi	Dosyalandı	Hisse	Durum	Amaç	Başvuru
Redmile Group, LLC, Green Jeremy, Redmile Biopharma Investments II, L.P., Redmile Strategic Long Only Trading Sub, Ltd. ×4 başvurular	24 Temmuz 2026	9,90%	Değişiklik	·	SEC
Panacea Innovation Limited, Panacea Venture Healthcare Fund II, L.P., Panacea Venture Healthcare Fund II GP Company, Ltd., Panacea Opportunity Fund I, L.P., Panacea Opportunity Fund I GP Company, Ltd., James Huang ×4 başvurular	11 Mayıs 2026	16,10%	Değişiklik	·	SEC
Adiumentum Capital Fund I LP, Adiumentum Capital Fund I GP LLC, Gregory A. Ciongoli ×3 başvurular	16 Mayıs 2025	19,99%	Değişiklik	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Şirket yöneticileri 35 içeriden öğrenenler · 19 yöneticiler · 16 yönetim kurulu üyeleri

19

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Alımlar 12ay	Satışlar 12ay	Net 12ay
Anhco Nguyen	President and CEO	17 Ağustos 2026 S	132.775	0	8	$-142.448
Isaac E. Ciechanover	Chief Executive Officer	30 Mayıs 2019 S	290.687	0	0	$0
Utpal Koppikar	Chief Financial Officer	02 Mart 2023 S	181.978	0	0	$0
John Mcgrath	EVP & Chief Financial Officer	20 Mart 2018 S	88.762	0	0	$0
Yanina Grant-Huerta	Chief Accounting Officer	18 Mayıs 2026 S	49.636	0	8	$-56.523
Jill Henrich	EVP, Chief Regulatory Officer	03 Mart 2025 S	18.679	0	0	$0
Amar Murugan	EVP, Chief Legal Officer	16 Ağustos 2024 S	26.827	0	0	$0
Manher Joshi	EVP, Chief Medical Officer	16 Kasım 2023 S	171.284	0	0	$0
Charlene A. Banard	EVP, Chief Technical Officer	16 Mayıs 2023 S	276.010	0	0	$0
Jakob Dupont	EVP, Head of R&D	02 Mart 2023 S	290.794	0	0	$0
Kristin Yarema	Chief Commercial Officer	01 Mart 2022 A	171.415	0	0	$0
Joe Newell	Chief Operations Officer	16 Kasım 2021 S	113.097	0	0	$0
Dietmar Berger	Global Head of R&D	07 Mayıs 2019 F	85.678	0	0	$0
Mina Kim	Senior VP & General Counsel	09 Nisan 2019 F	66.389	0	0	$0
Derrell Porter	SVP, Head of Global Commercial	26 Mart 2019 A	31.688	0	0	$0
Christopher Haqq	EVP, R&D & Chief Scientific Of	15 Şubat 2019 S	271.943	0	0	$0
Gad Soffer	EVP & Chief Strategy Officer	22 Eylül 2018 F	243.966	0	0	$0
Mitchall G. Clark	EVP & Chief R & QA Officer	18 Mayıs 2018 S	107.972	0	0	$0
Heather D Turner	Former EVP, GC & Sec.	09 Şubat 2018 S	69.494	0	0	$0
Brian N Cherry	Yönetim kurulu üyesi	04 Eylül 2026 P	166.486	1	0	$999.994
Gregory A. Ciongoli	Yönetim kurulu üyesi	09 Haziran 2026 A	12.000	0	0	$0
Matthew K Fust	Yönetim kurulu üyesi	09 Haziran 2026 A	30.188	0	0	$0
William K Heiden	Yönetim kurulu üyesi	09 Haziran 2026 A	34.188	0	0	$0
Ameet Mallik	Yönetim kurulu üyesi	10 Haziran 2025 A	16.928	0	0	$0
Maria Grazia Roncarolo	Yönetim kurulu üyesi	10 Haziran 2025 A	17.368	0	0	$0
Pascal Touchon	Yönetim kurulu üyesi	10 Haziran 2025 A	77.955	0	0	$0
Carol Giltner Gallagher	Yönetim kurulu üyesi	10 Haziran 2025 A	33.012	0	0	$0
Eric Dobmeier	Yönetim kurulu üyesi	10 Kasım 2023 P	563.325	0	0	$0
Beth C Seidenberg	Yönetim kurulu üyesi	31 Mayıs 2023 A	115.689	0	0	$0
Roy D. Baynes	Yönetim kurulu üyesi	23 Haziran 2022 A	43.500	0	0	$0
Ronald C Renaud JR	Yönetim kurulu üyesi	23 Haziran 2022 A	31.500	0	0	$0
Joel S Marcus	Yönetim kurulu üyesi	15 Mart 2019 S	888.355	0	0	$0
Eckard Weber	Yönetim kurulu üyesi	16 Ocak 2015 A	·	0	0	$0
EcoR1 Capital, LLC	10% sahip	07 Mayıs 2026 P	1.552.000	1	0	$4.744.255
Eric J Hyllengren	·	31 Mart 2025 D	56.231	0	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 4 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
IWC · iShares Trust	0,01%	18.824 SH	11 Eylül 2026	Günlük
VXF · VANGUARD INDEX FUNDS	0,00%	82.758 SH	19 Ağustos 2026	Günlük
VTI · VANGUARD INDEX FUNDS	0,00%	158.646 SH	19 Ağustos 2026	Günlük
DFAS · Dimensional ETF Trust	0,00%	135 NS	31 Temmuz 2026	N-PORT

ATRA Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21

derecelendirme · 10 analist AL

Medyan hedef $13.00 +37,1%

2 20,0% Güçlü Al

6 60,0% Al

2 20,0% Tut

0 0,0% Sat

0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

3 analist · 2026-10-02

Ortalama hedef $13.67 +44,2%

← Tüm hedeflerin altında Mevcut fiyat $9.48

Düşük$10.00 Ortalama$13.67 Yüksek$18.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
ATRA	$132M	7.0	-6.3%	27.1%	-88.9%	·
CNXU	·	·	·	·	·	·
RLYB	$4M	-0.4	34.9%	-1046.4%	-17.3%	·
MNOV	$64M	-5.5	·	-2928.8%	-27.1%	·
ICCC	·	-51.2	4.3%	·	·	·
ACRV	$76M	-1.2	·	·	-61.0%	·
SERA	·	-4.4	5.2%	-39417.3%	-39.0%	·
GRML	·	·	·	·	-104.9%	·
GANX	$135M	-5.3	-60.6%	·	-181.1%	·

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

ATRA Atara Biotherapeutics, Inc. - Common Stock